Stay updated on Dendritic Cell Cryo-Pembrolizumab in NHL Clinical Trial
Sign up to get notified when there's something new on the Dendritic Cell Cryo-Pembrolizumab in NHL Clinical Trial page.

Latest updates to the Dendritic Cell Cryo-Pembrolizumab in NHL Clinical Trial page
- CheckyesterdayChange DetectedThe page’s displayed platform revision/version has been updated from v3.5.2 to v3.5.3, reflecting a site release rather than a change to the clinical trial information.SummaryDifference0.0%

- Check8 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedAdded two MeSH terms—B-cell chronic lymphocytic leukemia and Malignant lymphoma, large B-cell, diffuse—to the Additional Relevant MeSH Terms.SummaryDifference0.1%

- Check37 days agoChange DetectedRevision added: v3.5.0. Revision removed: v3.4.3.SummaryDifference0.0%

- Check44 days agoChange DetectedRevision indicator updated from v3.4.2 to v3.4.3 in the page footer.SummaryDifference0.0%

- Check73 days agoChange DetectedSite maintenance updates include Revision: v3.4.2 and the removal of a prior funding notice (v3.4.1), which do not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Dendritic Cell Cryo-Pembrolizumab in NHL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dendritic Cell Cryo-Pembrolizumab in NHL Clinical Trial page.